Harald Schwalbe

Goethe University Frankfurt

Papers

2

Total Citations

12

H-Index

2

About

Harald Schwalbe is a prominent researcher whose work sits at the intersection of structural biology, biophysics, and drug discovery. His investigations into thermal shift assays — particularly nano-Differential Scanning Fluorimetry (nano-DSF) — have made meaningful contributions to the field of fragment-based lead discovery, a critical early stage in the development of new therapeutics. Schwalbe's research focuses on understanding how target proteins respond to changes in their molecular environment, specifically examining shifts in melting temperature (Tm) as a readout for protein-ligand interactions. By helping establish and validate nano-DSF as a reliable screening tool, his work has provided the drug discovery community with a sensitive, efficient, and accessible method for identifying promising molecular fragments that can be developed into lead compounds. His 2021 publications in this area have already begun accumulating citations, reflecting the practical value researchers and pharmaceutical scientists place on these methodologies. For students entering structural biology or medicinal chemistry, Schwalbe's work offers an important example of how rigorous biophysical characterization techniques can be translated into powerful tools that accelerate the earliest and most challenging stages of drug development.

Research Focus

Key Achievements

2
H-Index
2
Papers
12
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
7 citations · 2021
📈 Most Prolific Year: 2021 (2 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Goethe University Frankfurt

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 7 days ago